64
Participants
Start Date
January 1, 2024
Primary Completion Date
January 1, 2027
Study Completion Date
January 1, 2027
Apheresis
Participants will undergo two separate apheresis procedures, including: G-CSF primed hematopoietic stem cell collection and peripheral blood mononuclear cell apheresis for CAR-T cell manufacturing.
Autologous Stem Cell Transplantation
Participants are designed to receive myeloablative conditioning regimen prior to infusion of a minimum 2 x 10\^6 CD34+ stem cells/kilogram.
CAR-T Cell Therapy
CAR-T cells will be infused within 7 days after autologous hematopoietic stem cell infusion (2-10×10\^6 CAR-T/kg，ivgtt).
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
INDUSTRY
Suzhou Hongci Hematology Hospital, Suzhou, China
UNKNOWN
The First Affiliated Hospital of Soochow University
OTHER